Article

Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA Damage

2025-03-28

Abstract excerpt

Eliciting DNA damage in tumor cells continues to be one of the most successful strategies against cancer. This is the case for classical chemotherapy drugs and radiotherapy. In the modern era of personalized medicine, this strategy tries to identify specific vulnerabilities identified in each patient’s tumor, to inflict DNA damage in certain cell contexts that end up in massive cancer cell death. Cells rely on mul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 271c499c-8665-53b7-b7dd-69d449936f67
DOI: 10.20944/preprints202503.2214.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA DamageDOI 10.20944/preprints202503.2214.v1Read

Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA DamageSemantic proximity Read

Targeting DNA repair pathway in cancer: Mechanisms and clinical applicationSemantic proximity Read

Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid TumorsSemantic proximity Read

Advancing cancer therapy: new frontiers in targeting DNA damage responseSemantic proximity Read

Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapySemantic proximity Read

ATM and ATR as therapeutic targets in cancerSemantic proximity Read

DNA Damage Response Pathways in Tumor Suppression and Cancer TreatmentSemantic proximity Read

Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach.Semantic proximity Read

DNA damage checkpoint kinases in cancerSemantic proximity Read

Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translationSemantic proximity Read

Directing the use of DDR kinase inhibitors in cancer treatment.Semantic proximity Read

Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escapeSemantic proximity Read